Contact Lens Spectrum


April 2017

Document #257

(p. 14) Research Review – Keratoconus Is More Prevalent Than We Thought
By S. Barry Eiden, OD, & Milana Matz, OD

  1. Gokhale NS. Epidemiology of keratoconus. Indian J Ophthalmol. 2013 Aug;61(8):382-383.
  2. Eiden SB. Early keratoconus detection and management. Contact Lens Spectrum. 2014 Dec;29:12-13.
  3. Kennedy RH, Bourne WM, Dyer JA. A 48-year clinical and epidemiologic study of keratoconus. Am J Ophthalmol. 1986 Mar;101:267-273.
  4. Godefrooij DA, de Wit GA, Uiterwaal CS, Imhof SM, Wisse RPL. Age-specific incidence and prevalence of keratoconus: a nationwide registration study. Am J Ophthalmol. 2016 Dec 28. [Epub ahead of print]
  5. Millodot M, Shneor E, Albou S, Atlani E, Gordon-Shaag A. Prevalence and associated factors of keratoconus in Jerusalem – A cross-sectional study. Ophthalmic Epidemiol. 2011 Apr;18:91-97.
  6. Cozma I, Atherley C, James NJ. Influence of ethnic origin on the incidence of keratoconus and associated atopic disease in Asian and white patients. Eye (Lond). 2005 Aug;19:924-925.
  7. Gordon-Shaag A, Millodot M, Shneor E, Liu Y. The genetic and environmental factors for keratoconus. Biomed Res Int. 2015;2015:795738.
  8. Pearson AR, Soneji B, Sarvananthan N, Sanford-Smith JH. Does ethnic origin influence the incidence or severity of keratoconus? Eye (Lond). 2000 Aug;14:625-628.
  9. Shneor E, Millodot M, Blumberg S, Ortenberg I, Behrman S, Gordon-Shaag A. Characteristics of 244 patients with keratoconus seen in an optometric contact lens practice. Clin Exp Optom. 2013 Mar;96:219-224.
  10. Wagner H, Barr JT, Zadnik K. Collaborative longitudinal evaluation of keratoconus (CLEK) study: methods and findings to date. Cont Lens Anterior Eye. 2007 Sep;30:223-232.
  11. Alhayek A, Lu PR. Corneal collagen crosslinking in keratoconus and other eye disease. Int J Ophthalmol. 2015 Apr;8:407-418.
  12. Meiri Z, Keren S, Rosenblatt A, Sarig T, Shenhav L, Varssano D. Efficacy of corneal collagen cross-linking for the treatment of keratoconus: a systematic review and meta-analysis. Cornea. 2016 Mar;35:417-428.

(p. 17) GP Insights – GP Scientific Posters at the 2017 GSLS
By Edward S. Bennett, OD, MSEd

  1. Cunningham BT, Olson CK. Scleral Lenses Provide Improved Vision and Comfort to a Patient Struck by Lightning. Poster presented at the 2017 Global Specialty Lens Symposium, Jan. 2017, Las Vegas.
  2. DeNaeyer GW, Sanders DR, Farajian TS. Surface Coverage with Single vs. Multiple Gaze Surface Topography to Fit Scleral Lenses. Poster presented at the 2017 Global Specialty Lens Symposium, Jan. 2017, Las Vegas.
  3. Doan TT, Kolozhvari E, Lee R, Hernandez R. Assessing the HyperBond at the Junction of RGP and SiHy in SynergEyes Hybrid Duette Contact Lens. Poster presented at the 2017 Global Specialty Lens Symposium, Jan. 2017, Las Vegas.
  4. Yeung D, Sorbara L. A survey of scleral lens prescribing trends and complications. Poster presented at the 2017 Global Specialty Lens Symposium, Jan. 2017, Las Vegas.

(p. 20) Dry Eye Dx and Tx – Conjunctivochalasis, Contact Lenses, and Dry Eye
By William Townsend, OD

  1. Yamaguchi M, Nishijima T, Shimazaki J, Takamura E, Yokoi N, Watanabe H, Ohashi Y. Real-world assessment of diquafosol in dry eye patients with risk factors such as contact lens, meibomian gland dysfunction, and conjunctivochalasis: subgroup analysis from a prospective observational study. Clin Ophthalmol. 2015 Dec;9:2251-2256.
  2. The Epidemiology of Dry Eye Disease: Report of the Epidemiology Subcommittee of the International Dry Eye WorkShop (2007). Ocul Surf. 2007 Apr;5:93-107.
  3. Hughes WL. Conjuctivochalasis. Am J Ophthalmol. 1942 Jan;25:48-51.
  4. Németh J, Fodor E, Lang Z, Kosina-Hagyó K, Berta A, Komár T, Petricke I, Higazy M, Prost M, Grupcheva C, Kemer OE, Schollmayer P, Samaha A, Hlavackova. Lid-parallel conjunctival folds (LIPCOF) and dry eye: a multicentre study. Br J Ophthalmol. 2012 Nov;96:1380-1385.
  5. Francis IC, Chan DG, Kim P,Wilcsek G, Fillpic M, Yong J, Coroneo MT. Case-controlled clinical and histopathological study of conjunctivochalasis. Br J Ophthalmol. 2005 Mar;89:302-305.
  6. Meller D, Tseng SC. Conjunctivochalasis: Literature Review and Possible Pathophysiology. Surv Ophthalmol. 1988 Nov-Dec;43:225-232.
  7. Li DQ, Meller D, Liu Y, Tseng SC. Overexpression of MMP-1 and MMP-3 by cultured conjunctivochalasis fibroblasts. Invest Ophthalmol Vis Sci. 2000 Feb;41:404-410.
  8. Holden BA. The Glenn A. Fry Award lecture 1988: the ocular response to contact lens wear. Optom Vis Sci. 1989 Nov;66:717-733.
  9. Mimura T, Usui T, Yamamoto H, Yamagami S, Funatsu H, Noma H, Honda N, Fukuoka S, Amano S. Conjunctivochalasis and contact lenses. Am J Ophthalmol. 2009 Jul;148:20-25.
  10. Chhadva P, Alexander A, McClellan AL, McManus KT, Seiden B, Galor A. The impact of conjunctivochalasis on dry eye symptoms and signs. Invest Ophthalmol Vis Sci. 2015 May;56:2867-2871.
  11. Hara S, Kojima T, Ishida R, Goto E, Matsumoto Y, Kaido M, Shimazaki J, Dogru M, Tsubota K. Evaluation of tear stability after surgery for conjunctivochalasis. Optom Vis Sci. 2011 Sep;88:1112-1118.

(p. 22) Highlights from the 2017 GSLS
By Edward S. Bennett, OD, MSEd; Lisa Starcher; & Eef van der Worp, BOptom, PhD

  1. Vincent SJ, Alonso-Caneiro D, Collins MJ. Corneal changes following short-term miniscleral contact lens wear. Contact Lens Ant Eye. 2014 Dec;37:461-468.
  2. Alonso-Caneiro D, Vincent SJ, Collins MJ. Morphological changes in the conjunctiva, episclera and sclera following short-term miniscleral contact lens wear in rigid lens neophytes. Contact Lens Ant Eye. 2016 Feb;39:53-61.
  3. Walker MK. Laboratory analysis of scleral lens tear reservoir clouding. Poster presented at the Global Specialty Lens Symposium, Jan. 2014, Las Vegas.
  4. Borchman D, Foulks G, Yappert M, Bell J, Wells E, Neravetla S, Greenstone V. Human meibum lipid conformation and thermodynamic changes with meibomian-gland dysfunction. Invest Ophthalmol Vis Sci. 2011 Jun 1;52:3805-3817.
  5. Walker MK, Redfern RR. “Scleral lens surface coating improves vision and comfort.” Poster presented at the Tear Film and Ocular Surface Society meeting. September 2016, Montpelier, France.
  6. Read SA, Collins MJ, Vincent SJ. Light exposure and eye growth in childhood. Invest Ophthalmol Vis Sci. 2015 Oct;56:6779-6787.
  7. Papas EB, Tilia D, Tomlinson D, Williams J, Chan E, Chan J, Golebiowski B. Consequences of wear interruption for discomfort with contact lenses. Optom Vis Sci. 2014 Jan;91:24-31.
  8. Sulley A, Young G, Hunt C. Factors in the success of new contact lens wearers. Contact Lens Ant Eye. 2017 Feb;40:154-124.
  9. Van der Worp E, Hulscher J. Speed Date - CL-SAG meets OC-SAG: part 1. Global Contact. 2015(2):34-35.

(p. 32) Rules of Online Engagement
By Jason E. Compton, OD

  1. Telecommunication Development Bureau, International Telecommunication Union. ICT Facts and Figures 2005.
  2. Telecommunication Development Bureau, International Telecommunication Union. ICT Facts and Figures 2010. Available at . Accessed 24 May 2015.
  3. Telecommunication Development Bureau, International Telecommunication Union. ICT Facts and Figures 2014. Available at . Accessed 24 May 2015.
  4. Statistica. U.S. Population with a Social Media Profile 2016. Available at .
  5. Ng G. WhatsApp Reaches 1 Billion Users, 42 Billion Messages Sent Daily. iPhone in Canada. 2016 Feb 1. Available at . Accessed on Mar. 2, 2017.

(p. 36) Six Steps to Kickstart Your Practice’s Profits
By Jason R. Miller, OD, MBA

  1. Nichols JJ. Contact Lenses 2016. Contact Lens Spectrum. 2017 Jan;32:22-25, 27, 29, 55.

(p. 43) Is This the New Norm? – Is Calibrated Gland Expression the New Norm?
By Mile Brujic, OD, & David L. Kading, OD

  1. Nelson JD, Shimazaki J, Benitez-del-Castillo JM, Craig JP, McCulley JP, Den S, Foulks GN. The International Workshop on Meibomian Gland Dysfunction: Report of the Definition and Classification Subcommittee. Invest Ophthalmol Vis Sci. 2011 Mar;52:1930-1937.
  2. Korb DR, Blackie CA. Meibomian gland diagnostic expressibility: correlation with dry eye symptoms and gland location. Cornea. 2008 Dec;27:1142-1147.

(p. 47) Pediatric and Teen CL Care – Dry Eye in Children
By Melanie Frogozo, OD

  1. Moon JH, Kim KW, Moon NJ. Smartphone use is a risk factor for pediatric dry eye disease according to region and age: a case control study. BMC Ophthalmol. 2016 Oct 28;16:188.
  2. Akil H, Celik F, Ulas F, Kara IS. Dry Eye Syndrome and Allergic Conjunctivitis in the Pediatric Population. Middle East Afr J Ophthalmol. 2015 Oct-Dec;22:467-471.
  3. Akil H, Buluş AD, Andiran N, Alp MN. Ocular manifestations of Type 1 diabetes mellitus in pediatric population. Indian J Ophthalmol. 2016 Sep;64:654-658.
  4. Akinci A, Cakar N, Uncu N, Kara N, Acaroglu G. Keratoconjunctivitis sicca in juvenile rheumatoid arthritis. Cornea. 2007 Sep;26:941-944.
  5. Donaldson KE, Karp CL, Dunbar MT. Evaluation and treatment of children with ocular rosacea. Cornea. 2007 Jan;26:42-46.
  6. Faustino JF, Ribeiro-Silva A, Dalto RF, Souza MM, Furtado JM, Rocha Gde M, Alves M, Rocha EM. Vitamin A and the eye: an old tale for modern times. Arq Bras Oftalmol. 2016 Feb;79:56-61.

(p. 48) Prescribing for Astigmatism – Managing Refractive Flucuations Post-RK
By Britney Kitamata-Wong, OD; Grace Liao, OD; & Timothy B. Edrington, OD, MS

  1. Kemp JR, Martinez CE, Klyce SD, Coorpender SJ, McDonald MB, Lucci L, Lynn MJ, Waring GO. Diurnal fluctuations in corneal topography 10 years after radial keratotomy in the Prospective Evaluation of Radial Keratotomy Study. J Cataract Refract Surg. 1999 Jul;25:904-910.
  2. Chhadva P, Cabot F, Galor A, Yoo S. Long-term outcomes of radial keratotomy, laser in situ keratomileusis, and astigmatic keratotomy performed consecutively over a period of 21 years. Case Rep Ophthalmol Med. 2015;2015:592495.
  3. Edwards JD, Burka JM, Bower KS, Stutzman RD, Sediq DA, Rabin JC. Effect of brimonidine tartrate 0.15% on night-vision difficulty and contrast testing after refractive surgery. J Cataract Refract Surg. 2008 Sep;34:1538-1541. PubMed PMID: 18721716.

(p. 50) Treatment Plan – NO, NO, NO!
By Leo Semes, OD

  1. Huveneers S, Daemen MJAP, Hordijk PL. Between Rho(k) and a Hard Place. Circ Res. 2015 Feb 26;116:895-908. Available at . Accessed on Jan. 6, 2017.
  2. McMaster WG, Kirabo A, Madhur MS, Harrison DG. Inflammation, immunity, and hypertensive end-organ damage. Circ Res. 2015 Mar 13;116:1022-1033.
  3. Gradinarua D, Borsa C, Ionescu C, Prada GI. Oxidized LDL and NO synthesis—Biomarkers of endothelial dysfunction and ageing. Mech Ageing Dev. 2015 Nov;151:101-113.
  4. Vacek TP, Rehman S, Neamtu D, Yu S, Givimani S, Tyagi SC. Matrix metalloproteinases in atherosclerosis: role of nitric oxide, hydrogen sulfide, homocysteine, and polymorphisms. Vasc Health Risk Manag. 2015 Feb 27;11:173-183.
  5. Flammer J, Mozaffariaeh M. What is the present pathogenetic concept of glaucomatous optic neuropathy? Surv Ohthalmol. 2007 Nov;52 Suppl 2:S162-S173.
  6. Jia, Y, Wei E, Wang X, Zhang X, Morrison JC, Parikh M, Lombardi LH, Gattey DM, Armour RL, Edmunds B, Kraus MF, Fujimoto JG, Huang D. Optical coherence tomography angiography of optic disc perfusion in glaucoma. Ophthalmology. 2014 Jul;121:1322-1332.
  7. Karmel M. Glaucoma Pipeline Drugs: Targeting the Trabecular Meshwork. EyeNet Magazine. 2013 Oct:38-43.
  8. Ciotu IM, Stoian I, Gaman L, Popescu MV, Atanasiu V. Biochemical changes and treatment in glaucoma. J Med Life. 2015 Jan-Mar;8: 28-31.